Clinical Trials Directory

Trials / Completed

CompletedNCT03440853

Technology Assisted Stepped Collaborative Care Intervention

Technology Assisted Stepped Collaborative Care Intervention (TASCCI) to Improve Patient-centered Outcomes in Hemodialysis Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
160 (actual)
Sponsor
University of Pittsburgh · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study evaluates a collaborative care intervention in reducing depression, fatigue and pain symptoms and improving health related quality of life in hemodialysis patients. Half of participants will receive the collaborative care intervention, while the other half will receive technology delivered health education information.

Detailed description

End-stage renal disease patients on hemodialysis experience substantial symptom burden with fatigue, pain and depression among the most debilitating and existing as symptom clusters. These symptom clusters can exacerbate one another, and are independent and strong predictors of poor health-related quality of life in hemodialysis patients. This study will look at the effect of a 12 week stepped care intervention on changes in depression, pain or fatigue and health related quality of life.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTASCCITASCCI is a stepped-care collaborative care approach of pharmaco- and/or behavioral-therapy for a 12 week period. The intervention will target 1 or more symptoms based on patients' report of clinical levels of each symptom and patient preference. A trained behavioral therapist will deliver weekly video conferencing sessions during dialysis treatment.
OTHERTechnology Delivered Health Education InterventionThe Technology Delivered Health Education Intervention will deliver weekly video conferencing sessions to deliver online educational material from the National Kidney Foundation. These sessions will be delivered by a care coordinator.

Timeline

Start date
2018-03-28
Primary completion
2022-04-29
Completion
2022-06-30
First posted
2018-02-22
Last updated
2022-07-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03440853. Inclusion in this directory is not an endorsement.